First Robotical System for Eye Surgery of Spin-off Preceyes Goes to Oxford
March 4, 2016 | TU EindhovenEstimated reading time: 1 minute

Preceyes, a spin-off of TU/e, and Nightstar (UK) have entered into a collaboration for the development of a high-precision drug delivery technology in the eye. Nightstar will use the Preceyes robotic device to further refine the delivery of gene therapy to the subretinal space for a range of inherited retinal diseases. In the course of the collaboration, Nightstar will purchase the PRECEYES Surgical System for use in human gene therapy trials.
In a separate collaboration, a team led by Prof Robert MacLaren at the University of Oxford (UK), will be initiating human clinical trials using the PRECEYES Surgical System. Preceyes and the University have agreed to conduct an investigator-led clinical study, assessing the clinical functionality and applicability of the device. The focus of the study will be on high-precision vitreoretinal surgery which will facilitate future targeted drug delivery.
Preceyes’ high-precision robotic system targets ocular surgery, with vitreoretinal surgical procedures as the initial target market. The technology promises to improve the delivery of existing ocular surgery as well as enables the development of new treatments such as high-precision drug delivery, assisting eye surgeons in performing the most demanding surgical tasks.
David Fellows, CEO of Nightstar said, “Gene therapy has huge potential in retinal diseases and continuing to improve the precision and ease of delivery of the therapy are critical elements to success”. Robert MacLaren, Professor of Ophthalmology at the University of Oxford commented, “Over the last century, devices that enhance surgical precision have given us the greatest breakthroughs in ophthalmology. We are delighted to have approval for a clinical trial in Oxford which will be the first to assess use of a robotic device for surgery inside the eye."
Gerrit Naus, CEO of Preceyes said, “The collaborations with Nightstar and the University of Oxford are a major recognition of the unique value of our technology and its applicability to new treatments for unmet needs. We are very pleased to work closely with Nightstar and the University of Oxford to further mature the gene-therapy delivery and look forward to market adoption.”
Suggested Items
SEL Receives Purdue Senior Design Partner of the Year Award
05/01/2025 | Schweitzer Engineering LaboratoriesSchweitzer Engineering Laboratories (SEL) has been awarded the Senior Design Partner of the Year Award from the Edwardson School of Industrial Engineering at Purdue University.
IQM to Deploy Poland’s First Superconducting Quantum Computer
04/25/2025 | BUSINESS WIREThe first quantum computer in Poland developed by IQM Quantum Computers, a global leader in superconducting quantum computers, will be operational at the Wrocław University of Science and Technology (WUST) in the second quarter of this year.
Hon Hai Research Institute's Fourth-generation Semiconductor Application Reaches a New Milestone
04/21/2025 | FoxconnHon Hai Research Institute ( HHRI ) Semiconductor Research Institute has conducted cross-border cooperation with Yang Ming Chiao Tung University and the University of Texas at Austin to invest in forward-looking research on fourth-generation semiconductors.
University of Arizona Pioneering Technical Education Beyond Semiconductors
04/18/2025 | Marcy LaRont, PCB007 MagazineWhile many universities struggle to keep their curriculum up to date with the evolving needs of the electronics industry, the University of Arizona stands head and shoulders above the others. Its Center for Semiconductor Manufacturing incorporates five of the colleges at UA and emphasizes an interdisciplinary approach to prepare students for diverse careers in technology and manufacturing.
Tata Electronics Appoints KC Ang as President and Head of Tata Semiconductor Manufacturing
04/03/2025 | PRNewswireTata Electronics Private Limited, a pioneer in the Indian electronics and semiconductor manufacturing sector, announced the appointment of KC Ang as President and Head of its Foundry business - Tata Semiconductor Manufacturing Private Limited reporting to Dr. Randhir Thakur, CEO & MD of Tata Electronics.